43 - Combination of Oral Rigosertib and Injectable Azacitidine in Patients with Myelodysplastic Syndromes (MDS)

Autor: Navada, S., Garcia-Manero, G., Hearn, K., Odchimar-Reissig, R., Demakos, E., Fenaux, P., Petrone, M., Zbyszewski, P., Fruchtman, S., Silverman, L.
Zdroj: In Leukemia Research April 2017 55 Supplement 1:S30-S30
Databáze: ScienceDirect